Review is from 2014 and even though there is an update in 2017, as indicated it is for one of the very first models.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025